- Research works
- 31 ▲ 130% vs 2013–17
- Citations
- 1.3k 41.8 per fractional work
- Top-10% rate
- 6.7% record average 16.5%
- Open access
- 44% world 28%
Not ranked overall: National Psoriasis Foundation is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 45.2×. Every wedge is a field page.
Which keywords describe research at National Psoriasis Foundation?
By fractional works in all years, weighted toward what it does more of than the world: IL-17, TH17 Cells, Quality of Life, Ankylosing Spondylitis, Spondyloarthritis, Cost-effectiveness Analysis, Health Utility Measures and Filaggrin.
- Biological Therapy
- Inflammation
- Clinical Trials
- Skin Microbiome
- Epidemiology
- Cost-effectiveness Analysis
- Ankylosing Spondylitis
- TH17 Cells
- IL-17
- Quality of Life
- Spondyloarthritis
- Health Utility Measures
- Filaggrin
- Autoantibodies
- Cardiovascular Risk
- Rheumatoid Arthritis
- Disease-Modifying Antirheumatic Drugs
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 17 words, with their numbers
- IL-179▲ 1193×1 topic
- TH17 Cells9▲ 1193×1 topic
- Quality of Life4▲ 9.5×5 topics
- Ankylosing Spondylitis4▲ 526×1 topic
- Spondyloarthritis4▲ 526×1 topic
- Cost-effectiveness Analysis4▲ 150×1 topic
- Health Utility Measures4▲ 150×1 topic
- Epidemiology2▲ 1.63×12 topics
- Filaggrin2▲ 157×1 topic
- Skin Microbiome2▲ 157×1 topic
- Autoantibodies2▲ 26×3 topics
- Clinical Trials1▲ 7.5×5 topics
- Cardiovascular Risk1▲ 12×2 topics
- Inflammation1▲ 1.82×3 topics
- Rheumatoid Arthritis1▲ 43×2 topics
- Biological Therapy1▲ 72×1 topic
- Disease-Modifying Antirheumatic Drugs1▲ 82×1 topic
Which research topics does National Psoriasis Foundation publish most on?
By volume in 2022–2025: Psoriasis: Treatment and Pathogenesis, Health Systems, Economic Evaluations, Quality of Life, Spondyloarthritis Studies and Treatments and Rheumatoid Arthritis Research and Therapies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Psoriasis: Treatment and Pathogenesis Immunology 3 works
- 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 3 Spondyloarthritis Studies and Treatments Rheumatology 1 works
- 4 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
- 5 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
- 6 Dermatology and Skin Diseases Dermatology 0 works
- 7 Biosimilars and Bioanalytical Methods Immunology 0 works
- 8 Pharmaceutical industry and healthcare Pharmacology 0 works
- 9 Therapeutic Uses of Natural Elements Complementary and Manual Therapy 0 works
- 10 Medicine and Dermatology Studies History Dermatology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has National Psoriasis Foundation's research output changed?
Output in 2018–2022 was 130% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Portland
- Oregon Health & Science University
- Portland State University
- University of Portland
- Lewis & Clark College
- Reed College
- Portland VA Medical Center
- Pacific Northwest Research Station
- Oregon Medical Research Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.